Evidence map›Paper›PMID 33197265›Full record

ArticleAmerican journal of hypertension2021

Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study.

Conor Judge, Martin J O'Donnell, Graeme J Hankey, Sumathy Rangarajan, Siu Lim Chin, Purnima Rao-Melacini, John Ferguson, Andrew Smyth, Denis Xavier, Liu Lisheng and 27 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of hypertension, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Electrolyte Imbalance and Neurologic Injury.CNS & neurological disorders drug targets · 2024
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 25 countries.

Conor JudgeDepartment of Medicine, NUI Galway, Galway, Ireland.
Martin J O'DonnellDepartment of Medicine, NUI Galway, Galway, Ireland.
Graeme J HankeySchool of Medicine and Pharmacology, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
Sumathy RangarajanDepartment of Medicine, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
Siu Lim ChinDepartment of Medicine, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
Purnima Rao-MelaciniDepartment of Medicine, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
John FergusonDepartment of Medicine, NUI Galway, Galway, Ireland.
Andrew SmythDepartment of Medicine, NUI Galway, Galway, Ireland.
Denis XavierDepartment of Medicine, St John's Medical College and Research Institute, Bangalore, India.
Liu LishengDepartment of Medicine, National Center of Cardiovascular Disease, Beijing, China.
Hongye ZhangDepartment of Medicine, Beijing Hypertension League Institute, Beijing, China.
Patricio Lopez-JaramilloDepartment of Medicine, Instituto de Investigaciones MASIRA, Universidad de Santander, Bucaramanga, Colombia.
Albertino DamascenoFaculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Peter LanghorneDepartment of Medicine, Glasgow Royal Infirmary, University of Glasgow, Glasgow, Scotland, UK.
Annika RosengrenDepartment of Molecular and Clinical Medicine, University of Gothenburg and Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Antonio L DansCollege of Medicine, University of Philippines, Manila, Philippines.
Ahmed ElsayedDepartment of Surgery, Al Shaab Teaching Hospital, Khartoum, Sudan.
Alvaro AvezumDepartment of Medicine, International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Charles MondoDepartment of Medicine, Kiruddu National Referral Hospital, Kampala, Uganda.
Danuta RyglewiczMilitary Institute of Aviation Medicine, Warsaw, Poland.
Anna CzlonkowskaDepartment of Medicine, Military Institute of Aviation Medicine, Warsaw, Poland.
Nana PogosovaDepartment of Medicine, National Medical Research Center of Cardiology, Moscow, Russia.
Christian WeimarDepartment of Neurology, University Hospital, Essen, Germany.
Rafael DiazDepartment of Medicine, Estudios Clínicos Latino America (ECLA), Instituto Cardiovascular de Rosario (ICR), Rosario, Argentina.
Khalid YusoffDepartment of Medicine, Universiti Teknologi MARA, Selayang, Selangor and UCSI University, Kuala Lumpur, Malaysia.
Afzalhussein YusufaliDepartment of Medicine, Hatta Hospital, Dubai Health Authority/Dubai Medical College, Dubai, UAE.
Aytekin OguzDepartment of Internal Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Xingyu WangDepartment of Medicine, Beijing Hypertension League Institute, Beijing, China.
Fernando LanasFaculty of Medicine, Universidad de La Frontera, Temuco, Chile.
Okechukwu S OgahDepartment of Medicine, University College Hospital, Ibadan, Nigeria.
Adesola OgunniyiDepartment of Medicine, University College Hospital, Ibadan, Oyo State, Nigeria.
Helle K IversenDepartment of Neurology, Rigshospitalet, University of Copenhagen, Denmark.
German MalagaSchool of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
Zvonko RumboldtDepartment of Medicine, University of Split, Split, Croatia.
Shahram OveisgharanDepartment of Medicine, Rush Alzheimer Disease Research Center in Chicago, Chicago, Illinois, USA.
Fawaz Al HussainDepartment of Medicine, King Saud University, Riyadh, Saudi Arabia.
Salim YusufDepartment of Medicine, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
Ollscoil na Gaillimhe – University of Galway · IEPopulation Health Research Institute · CAShanghai Institute of Hypertension · CNUniversity College Hospital, Ibadan · NGWojskowy Instytut Medycyny Lotniczej · PLDubai Health Authority · AEEduardo Mondlane University · MZEssen University Hospital · DEGlasgow Royal Infirmary · GBHospital Alemão Oswaldo Cruz · BRInstituto Cardiovascular de Rosario · ARIstanbul Medeniyet University · TRKing Saud University · SANational Clinical Research Center for Digestive Diseases · CNNational Medical Research Center of Cardiology · RURush University · USSahlgrenska University Hospital · SESt.John's Medical College Hospital · INThe University of Western Australia · AUUCSI University · MY

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundAlthough low sodium intake (<2 g/day) and high potassium intake (>3.5 g/day) are proposed as public health interventions to reduce stroke risk, there is uncertainty about the benefit and feasibility of this combined recommendation on prevention of stroke.

methodsWe obtained random urine samples from 9,275 cases of acute first stroke and 9,726 matched controls from 27 countries and estimated the 24-hour sodium and potassium excretion, a surrogate for intake, using the Tanaka formula. Using multivariable conditional logistic regression, we determined the associations of estimated 24-hour urinary sodium and potassium excretion with stroke and its subtypes.

resultsCompared with an estimated urinary sodium excretion of 2.8-3.5 g/day (reference), higher (>4.26 g/day) (odds ratio [OR] 1.81; 95% confidence interval [CI], 1.65-2.00) and lower (<2.8 g/day) sodium excretion (OR 1.39; 95% CI, 1.26-1.53) were significantly associated with increased risk of stroke. The stroke risk associated with the highest quartile of sodium intake (sodium excretion >4.26 g/day) was significantly greater (P < 0.001) for intracerebral hemorrhage (ICH) (OR 2.38; 95% CI, 1.93-2.92) than for ischemic stroke (OR 1.67; 95% CI, 1.50-1.87). Urinary potassium was inversely and linearly associated with risk of stroke, and stronger for ischemic stroke than ICH (P = 0.026). In an analysis of combined sodium and potassium excretion, the combination of high potassium intake (>1.58 g/day) and moderate sodium intake (2.8-3.5 g/day) was associated with the lowest risk of stroke.

conclusionsThe association of sodium intake and stroke is J-shaped, with high sodium intake a stronger risk factor for ICH than ischemic stroke. Our data suggest that moderate sodium intake-rather than low sodium intake-combined with high potassium intake may be associated with the lowest risk of stroke and expected to be a more feasible combined dietary target.

Indexed as

Hemorrhagic StrokeIschemic StrokePotassiumSodiumCase-Control StudiesHumansPotassium, DietaryRisk AssessmentSodium, DietaryPotassiumPotassium, DietarySodiumSodium, Dietaryblood pressurehypertensionintracerebral hemorrhageischemic strokepotassiumsodiumstroke

Identifiers

PMID33197265
PMCPMC8057138
OpenAlexW3102453111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.